The Breast Cancer Research Program challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, facilitate multidisciplinary collaborations, and support future breast cancer leaders.
The Breast Cancer Landscape
- This overview describes what is currently known about breast cancer incidence, death, recurrence, metastatic disease, risk factors, and treatments.
- Considering the current breast cancer landscape and the BCRP’s vision to end breast cancer, the FY13 BCRP seeks applications that address the following overarching challenges:
- Eliminate the mortality associated with metastatic breast cancer
- Prevent breast cancer (primary prevention)
- Distinguish aggressive breast cancer from indolent cancers; overcome the problems of over-diagnosis and over-treatment
- Revolutionize treatment regimens by replacing drugs that have life-threatening toxicities with safe, effective interventions
- Identify what drives breast cancer growth and metastasis; identify why some breast cancers become life-threatening metastases
- Identify what makes the breast susceptible to cancer development
- Determine why some, but not all, women get breast cancer
- Determine why/how breast cancer cells lay dormant for years and then re-emerge (recurrence); determine how to eliminate dormant cells early
Breast Cancer Research Semipostal
- $22.6 million received to date
- Breast Cancer Stamp Program Booklet
Congressional Appropriations
- $2.66 billion in FY92 -11
- $120 million in FY12
Funding Summary
- 6,194 Awards in FY92-11
- Recent Applications Recommended for Funding
- Program Portfolio
Integration Panels
